| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Departments of Gastrointestinal Medical Oncology [D. W., E. L. R., K. Z., L. W., X. L., Y. H., K. X.], Neurosurgery [S. H.], and Cancer Biology [S. H., K. X.], The University of Texas M. D. Anderson Cancer Center, and the Program in Cancer Biology, The University of Texas Graduate School of Biomedical Sciences at Houston [E. L. R., K. Z., S. H., K. X.], Houston, Texas 77030
Inducible nitric oxide synthase (NOS) II expression can be induced in the tumor bed, predominantly in host cells that infiltrate and surround a tumor. However, the impact of this physiological NOS II expression in host cells on tumor growth and metastasis remains unclear because of a lack of appropriate experimental approaches. In the present study, three NOS II-null (NOS II-/-) tumor cell lines, KX-dw1, KX-dw4, and KX-dw7, were established and verified using Southern, Northern, and Western blot analysis, and nitric oxide production assays. Cells from these lines were then s.c. and i.v. injected into NOS II+/+ and NOS II-/- C57BL/6 mice. NOS II protein expression and enzyme activity were clearly detected in the tumors that formed in NOS II+/+ mice but not in those that formed in NOS II-/- mice. Consistent with the absence of NOS II expression in the tumor stroma, KX-dw1, KX-dw4, and KX-dw7 cells grew much faster and produced many more experimental lung metastases in NOS II-/- mice than in NOS II+/+ mice. Therefore, physiological expression of NOS II in host cells directly inhibits tumor growth and metastasis.
This article has been cited by other articles:
![]() |
X. Zhao, M. Mohaupt, J. Jiang, S. Liu, B. Li, and Z. Qin Tumor Necrosis Factor Receptor 2-Mediated Tumor Suppression Is Nitric Oxide Dependent and Involves Angiostasis Cancer Res., May 1, 2007; 67(9): 4443 - 4450. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Hollenbaugh and R. W. Dutton IFN-{gamma} Regulates Donor CD8 T Cell Expansion, Migration, and Leads to Apoptosis of Cells of a Solid Tumor. J. Immunol., September 1, 2006; 177(5): 3004 - 3011. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Lancaster Jr. and K. Xie Tumors Face NO Problems? Cancer Res., July 1, 2006; 66(13): 6459 - 6462. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Le, D. Wei, S. Huang, J. R. Lancaster Jr., and K. Xie Nitric oxide synthase II suppresses the growth and metastasis of human cancer regardless of its up-regulation of protumor factors PNAS, June 14, 2005; 102(24): 8758 - 8763. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Thomas, M. G. Espey, L. A. Ridnour, L. J. Hofseth, D. Mancardi, C. C. Harris, and D. A. Wink Hypoxic inducible factor 1{alpha}, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide PNAS, June 15, 2004; 101(24): 8894 - 8899. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |